India to Japan: Mitomycin Export Trade Route

The India to Japan Mitomycin corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $322.0K USD. The route is dominated by INTAS PHARMACEUTICALS LTD, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's mitomycin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $53.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with mitomycin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 16.9%, placing it at rank #10 among India's top mitomycin export destinations globally.

On the import side, key buyers of Indian mitomycin in Japan include KYOWA KIRIN CO LTD, XXOWAXXIRIXXCO XXLIMITEDX, KYOWA KIRIN CO LIMITED. KYOWA KIRIN CO LTD is the single largest importer with 3 shipments valued at $215.7K USD.

India's mitomycin exports to Japan are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LTD with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $53.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as mitomycin powd for sol 2mg/vial(kkc-jp) and mitomycin powd for sol 2mg/vialkkc-jp, suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KYOWA KIRIN CO LTD is the largest importer with 3 shipments worth $215.7K USD — representing 67% of all mitomycin imports from India on this route.